Man Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $94.5M | Sell |
678,066
-1,047,046
| -61% | -$147M | 0.17% | 131 |
|
|
2025
Q4 | $212M | Sell |
1,725,112
-31,479
| -2% | -$3.83M | 0.36% | 56 |
|
|
2025
Q3 | $195M | Buy |
1,756,591
+181,636
| +12% | +$20.6M | 0.34% | 55 |
|
|
2025
Q2 | $175M | Sell |
1,574,955
-89,633
| -5% | -$9.54M | 0.33% | 58 |
|
|
2025
Q1 | $187M | Buy |
1,664,588
+791,409
| +91% | +$81.7M | 0.47% | 29 |
|
|
2024
Q4 | $80.7M | Buy |
873,179
+243,567
| +39% | +$21.9M | 0.21% | 106 |
|
|
2024
Q3 | $52.8M | Sell |
629,612
-560,079
| -47% | -$42.7M | 0.14% | 177 |
|
|
2024
Q2 | $81.6M | Buy |
1,189,691
+198,367
| +20% | +$13.2M | 0.21% | 110 |
|
|
2024
Q1 | $72.6M | Buy |
991,324
+531,975
| +116% | +$40.9M | 0.18% | 122 |
|
|
2023
Q4 | $37.2M | Buy |
+459,349
| New | +$35.7M | 0.1% | 224 |
|
|
2023
Q3 | – | Sell |
-1,108,577
| Closed | -$85.3M | – | 180 |
|
|
2023
Q2 | $85.4M | Buy |
+1,108,577
| New | +$88.4M | 0.26% | 75 |
|
|
2023
Q1 | – | Sell |
-2,298,890
| Closed | -$190M | – | 36 |
|
|
2022
Q4 | $197M | Buy |
2,298,890
+643,986
| +39% | +$51M | 0.71% | 13 |
|
|
2022
Q3 | $102M | Buy |
+1,654,904
| New | +$104M | 0.47% | 29 |
|
|
2022
Q2 | – | Sell |
-997,530
| Closed | -$61.8M | – | 44 |
|
|
2022
Q1 | $59.3M | Buy |
997,530
+335,895
| +51% | +$21.5M | 0.21% | 109 |
|
|
2021
Q4 | $48M | Buy |
661,635
+278,407
| +73% | +$19.2M | 0.15% | 140 |
|
|
2021
Q3 | $26.8M | Sell |
383,228
-151,229
| -28% | -$10.6M | 0.09% | 247 |
|
|
2021
Q2 | $36.8M | Sell |
534,457
-717,941
| -57% | -$47.9M | 0.13% | 167 |
|
|
2021
Q1 | $80.9M | Buy |
1,252,398
+30,087
| +2% | +$1.94M | 0.36% | 54 |
|
|
2020
Q4 | $71.2M | Buy |
1,222,311
+7,794
| +0.6% | +$470K | 0.31% | 59 |
|
|
2020
Q3 | $76.7M | Buy |
1,214,517
+176,817
| +17% | +$12.3M | 0.3% | 66 |
|
|
2020
Q2 | $79.8M | Buy |
1,037,700
+460,474
| +80% | +$35.3M | 0.4% | 45 |
|
|
2020
Q1 | $43.2M | Sell |
577,226
-1,527,638
| -73% | -$106M | 0.28% | 80 |
|
|
2019
Q4 | $137M | Sell |
2,104,864
-502,571
| -19% | -$32.7M | 0.45% | 34 |
|
|
2019
Q3 | $165M | Sell |
2,607,435
-879,926
| -25% | -$57.5M | 0.61% | 22 |
|
|
2019
Q2 | $236M | Sell |
3,487,361
-631,906
| -15% | -$41.6M | 0.85% | 9 |
|
|
2019
Q1 | $268M | Buy |
4,119,267
+189,698
| +5% | +$12.6M | 1.02% | 4 |
|
|
2018
Q4 | $246M | Buy |
3,929,569
+744,177
| +23% | +$52M | 1.09% | 8 |
|
|
2018
Q3 | $246M | Buy |
3,185,392
+949,348
| +42% | +$71.7M | 0.9% | 8 |
|
|
2018
Q2 | $158M | Buy |
2,236,044
+104,335
| +5% | +$7.37M | 0.65% | 20 |
|
|
2018
Q1 | $161M | Buy |
+2,131,709
| New | +$169M | 0.74% | 17 |
|
Other funds holding GILD
VCM
VPM
Man Group's GILD Position: Q1 2026 in Review
Man Group reduced its Gilead Sciences (GILD) stake by 61% in Q1 2026, selling an estimated $147M and leaving 678,066 shares worth $94.5M. The position accounts for 0.17% of the portfolio, ranked #131.
Man Group first reported a position in GILD in Q1 2018 and has held it in 30 quarters since. The position peaked at $268M in Q1 2019. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Man Group held 678,066 shares of Gilead Sciences worth $94.5M as of Q1 2026.
- Man Group sold 1,047,046 Gilead Sciences shares in Q1 2026, an estimated $147M.
- Gilead Sciences made up 0.17% of Man Group's portfolio in Q1 2026, its #131 holding.
- Man Group first reported a position in Gilead Sciences in Q1 2018 and has held it in 30 quarters since.
- Man Group's Gilead Sciences position peaked at $268M in Q1 2019.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.